A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Liquidia Corp stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 31,566 shares of LQDA stock, worth $320,394. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31,566
Previous 26,032 21.26%
Holding current value
$320,394
Previous $312,000 0.96%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$8.9 - $14.11 $49,252 - $78,084
5,534 Added 21.26%
31,566 $315,000
Q2 2024

Aug 14, 2024

BUY
$11.96 - $15.71 $311,342 - $408,962
26,032 New
26,032 $312,000

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $653M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.